Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 May 17;79(7):1597–1605. doi: 10.1093/jac/dkae147

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2024. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 1. — Geometric mean (95% CI—dashed lines) concentrations in plasma and urine for (a) tenofovir (tenofovir alafenamide; TFV_TAF), (b) emtricitabine (FTC), (c) tenofovir (tenofovir disoproxil; TFV_TDF), (d) lamivudine (3TC) and (e) dolutegravir (DTG) (Arm 1) and (f) DTG (Arm 2), during the 14 day drug intake cessation period. Plasma values are indicated with grey lines (circles) and urine values with black lines (triangles). Detectable concentrations below the assay LLQ are expressed as half-LLQ values.